ETAA1 and neoplasm: UALCAN analysis indicated a preferential up-regulation of ETAA1 and RPA1 in advanced liver cancer stages (Figures 3A, C) and in poorly differentiated tumor grades (Figures 3B, D), when compared to normal tissue controls.